null

Anti-Human CD194 (CCR4) (Mogamulizumab) - Fc Reduced Biotin Biosimilar (IVMB0423)

SKU:
IVMB0423
Antibody Type:
Biotinylated Biosimilar
Modifications:
Biotinylated
Applications:
SPR
ELISA
Drug Development
Pharmacokinetics
Disease Area:
B-Cell Malignancies
Disease Area:
Immunotherapy
€819

Description

system_update_altDatasheetsystem_update_altMSDS